ACADIA Pharmaceuticals Investor Relations Material
Latest events
Q2 2025
ACADIA Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ACADIA Pharmaceuticals Inc
Access all reports
ACADIA Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of therapies addressing central nervous system disorders. The company offers treatments for conditions such as Parkinson’s disease psychosis and other neurological diseases. ACADIA operates within the healthcare sector, concentrating on innovative solutions for underserved medical needs. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for ACADIA Pharmaceuticals Inc
R&D Day 2025
ACADIA Pharmaceuticals Inc
R&D Day 2025
ACADIA Pharmaceuticals Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ACAD
Country
🇺🇸 United States